Genetic variations observed in arterial and venous thromboembolism - Relevance for therapy, risk prevention and prognosis

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 4, 2003, Pages 496-500

  Harrington, Dominic J ^a   Malefora, Agata ^a   Schmeleva, Veronika ^b   Kapustin, Sergey ^b   Papayan, Ludmila ^b   Blinov, Mikhail ^b   Harrington, Pip ^a   Mitchell, Mike ^a   Savidge, Geoffrey F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Russian Institute of Haematology and Transfusion   (Russian Federation)

Author keywords

Fibrinogen dimorphism; Arterial and venous thromboembolism; Factor V Leiden; Homocysteine; MTHFR mutation; Pulmonary embolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CYANOCOBALAMIN; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; ALLELE; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; CHEMICAL ANALYSIS; CLINICAL OBSERVATION; COFFEE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; LIFESTYLE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SCREENING TEST; SEX DIFFERENCE; SMOKING; SURVIVAL; THROMBOEMBOLISM; TREATMENT PLANNING; VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION;

ADULT; ARTERIAL OCCLUSIVE DISEASES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FACTOR V; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; PROTHROMBIN; THROMBOEMBOLISM; VARIATION (GENETICS); VENOUS THROMBOSIS;

EID: 0038059033     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.075     Document Type: Article

References (15)

1. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver C, editor. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995: 1279-327.
2. Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ. Hyperhomocysteinemia and venous thrombosis: a metaanalysis. Thromb Haemost 1998; 80:874-7.
3. Makris M. Hyperhomocysteinemia and thrombosis. Clin Lab Haem 2000; 22:133-43.
4. Morelli VM, Lourenço DM, D'Almeida V, Franco RF, Miranda F, Zago M, et al. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 2002; 13:271-5.
5. Brouwer IA, Dusseldorp M, West CE, Meyboom S, Thomas CMG, Duran M, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 1999; 129:1135-9.
6. Clarke R. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998; 316:894-8.
7. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124:1927-33.
8. Arruda VR, von Zoben PM, Chiamparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77:818-21.
9. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, deRonde H, et al. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994; 369:64-7.
10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-703.
11. Fiskerstrand, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263-71.
12. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 1999; 81:733-8.
13. Matinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crost F, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92:2353-8.
14. Kapustin SI, Blinov MN, Papayan LP, Imyanitov EN, Mitchell MJ, Savidge GF. Under-representation of the -455A β-fibrinogen allele in survivors of pulmonary embolism. Thromb Res 2002; 106:89-90.
15. Thomas AE, Green FR, Lamlum H, Humphries SE. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers. J Med Genet 1995; 32:585-9.